Antibiotics for the treatment of primary sclerosing cholangitis

Diaa Aldin H Elfaki, Keith Lindor

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease that is associated with considerable morbidity and mortality. The disease etiopathogenesis has not been well defined. Several observations suggest that portal bacteremia or chronic bile duct infection may be factors that could play a role in the pathogenesis of the disease. Clinical trials have tested different treatments for PSC but without convincing evidence of benefit. Liver transplantation is the only available therapeutic option that is thought to be beneficial for PSC. Antibiotics have been used in several case series over the years to treat PSC and have had, in some cases, impressive benefits when compared with other drugs used for treating the disease. We gathered the available data for different antibiotics used in PSC in this review. Further studies are needed to support the efficacy of using antibiotics for PSC patients.

Original languageEnglish (US)
Pages (from-to)261-265
Number of pages5
JournalAmerican Journal of Therapeutics
Volume18
Issue number3
DOIs
StatePublished - May 2011
Externally publishedYes

Fingerprint

Sclerosing Cholangitis
Anti-Bacterial Agents
Therapeutics
Bacteremia
Bile Ducts
Liver Transplantation
Liver Diseases
Clinical Trials
Morbidity
Mortality
Infection
Pharmaceutical Preparations

Keywords

  • antibiotics
  • primary sclerosing cholangitis

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Antibiotics for the treatment of primary sclerosing cholangitis. / Elfaki, Diaa Aldin H; Lindor, Keith.

In: American Journal of Therapeutics, Vol. 18, No. 3, 05.2011, p. 261-265.

Research output: Contribution to journalArticle

@article{d5d8bb08df7d46278fa58226eccf1a4e,
title = "Antibiotics for the treatment of primary sclerosing cholangitis",
abstract = "Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease that is associated with considerable morbidity and mortality. The disease etiopathogenesis has not been well defined. Several observations suggest that portal bacteremia or chronic bile duct infection may be factors that could play a role in the pathogenesis of the disease. Clinical trials have tested different treatments for PSC but without convincing evidence of benefit. Liver transplantation is the only available therapeutic option that is thought to be beneficial for PSC. Antibiotics have been used in several case series over the years to treat PSC and have had, in some cases, impressive benefits when compared with other drugs used for treating the disease. We gathered the available data for different antibiotics used in PSC in this review. Further studies are needed to support the efficacy of using antibiotics for PSC patients.",
keywords = "antibiotics, primary sclerosing cholangitis",
author = "Elfaki, {Diaa Aldin H} and Keith Lindor",
year = "2011",
month = "5",
doi = "10.1097/MJT.0b013e3181b7b8c0",
language = "English (US)",
volume = "18",
pages = "261--265",
journal = "American Journal of Therapeutics",
issn = "1075-2765",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Antibiotics for the treatment of primary sclerosing cholangitis

AU - Elfaki, Diaa Aldin H

AU - Lindor, Keith

PY - 2011/5

Y1 - 2011/5

N2 - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease that is associated with considerable morbidity and mortality. The disease etiopathogenesis has not been well defined. Several observations suggest that portal bacteremia or chronic bile duct infection may be factors that could play a role in the pathogenesis of the disease. Clinical trials have tested different treatments for PSC but without convincing evidence of benefit. Liver transplantation is the only available therapeutic option that is thought to be beneficial for PSC. Antibiotics have been used in several case series over the years to treat PSC and have had, in some cases, impressive benefits when compared with other drugs used for treating the disease. We gathered the available data for different antibiotics used in PSC in this review. Further studies are needed to support the efficacy of using antibiotics for PSC patients.

AB - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease that is associated with considerable morbidity and mortality. The disease etiopathogenesis has not been well defined. Several observations suggest that portal bacteremia or chronic bile duct infection may be factors that could play a role in the pathogenesis of the disease. Clinical trials have tested different treatments for PSC but without convincing evidence of benefit. Liver transplantation is the only available therapeutic option that is thought to be beneficial for PSC. Antibiotics have been used in several case series over the years to treat PSC and have had, in some cases, impressive benefits when compared with other drugs used for treating the disease. We gathered the available data for different antibiotics used in PSC in this review. Further studies are needed to support the efficacy of using antibiotics for PSC patients.

KW - antibiotics

KW - primary sclerosing cholangitis

UR - http://www.scopus.com/inward/record.url?scp=79958051295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958051295&partnerID=8YFLogxK

U2 - 10.1097/MJT.0b013e3181b7b8c0

DO - 10.1097/MJT.0b013e3181b7b8c0

M3 - Article

C2 - 19770792

AN - SCOPUS:79958051295

VL - 18

SP - 261

EP - 265

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 3

ER -